NanoViricides (NNVC) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts NNVC Hot Sheet
Join SI Premium – FREE
NanoViricides (NYSE: NNVC) reported Q1 EPS of $0.00, versus ($0.04) reported last year. Loss from operations narrower from $1.89 million down to $1.69 million.
For earnings history and earnings-related data on NanoViricides (NNVC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
